Tacrolimus ointment for the treatment of vulvar lichen sclerosus - 29/08/11
Abstract |
The treatment of vulvar lichen sclerosus is generally considered difficult. Ultrapotent corticosteroids represent the most effective topical treatment, but carry the risk of side effects such as skin atrophy. We describe a 71-year-old woman with long-standing vulvar lichen sclerosus refractory to conventional treatment. After 6 consecutive weeks of treatment with tacrolimus ointment 0.1% (Protopic) twice daily, signs and symptoms of lichen sclerosus resolved. To our knowledge, this is the first report of the use of topical tacrolimus, which does not induce skin atrophy, in the treatment of vulvar lichen sclerosus. (J Am Acad Dermatol 2003;48:935-7.)
Le texte complet de cet article est disponible en PDF.Plan
 | Funding sources: None. |
| Conflict of interest: None identified. |
 | Reprint requests: Thomas Ruzicka, MD, Department of Dermatology, Heinrich-Heine-University, Moorenstr. 5, D-40225 Duesseldorf, Germany. E-mail: ruzicka@uni-duesseldorf.de. |
| 0190-9622/2003/$30.00 + 0 |
Vol 48 - N° 6
P. 935-937 - juin 2003 Retour au numéro
Article précédent
- Iotaderma #113
- Diffuse neurofibroma on the lower back
- E.J. van Zuuren, A.N. Posma
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?